APPIAN CORP
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
APPN$51.60-4.5%Stored close · as of Nov 6, 2026
Contents
Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value and share data)
| As of | ||
|---|---|---|
| March 31, 2025 | December 31, 2024 | |
| (unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $134,982 | $118,552 |
| Short-term investments and marketable securities | 64,716 | 41,308 |
| Accounts receivable, net of allowance of $2,323 and $3,396, respectively | 136,037 | 195,069 |
| Deferred commissions, current | 34,858 | 36,630 |
| Prepaid expenses and other current assets | 41,309 | 43,984 |
| Total current assets | 411,902 | 435,543 |
| Property and equipment, net of accumulated depreciation of $34,326 and $32,142, respectively | 36,330 | 37,109 |
| Goodwill | 26,546 | 25,555 |
| Intangible assets, net of accumulated amortization of $5,842 and $5,341, respectively | 2,032 | 2,240 |
| Right-of-use assets for operating leases | 31,645 | 31,081 |
| Deferred commissions, net of current portion | 58,457 | 60,540 |
| Deferred tax assets | 4,388 | 4,129 |
| Other assets | 21,599 | 24,842 |
| Total assets | $592,899 | $621,039 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities | ||
| Accounts payable | $6,574 | $4,322 |
| Accrued expenses | 13,825 | 11,388 |
| Accrued compensation and related benefits | 26,487 | 34,223 |
| Deferred revenue | 258,582 | 281,760 |
| Debt | 9,598 | 9,598 |
| Operating lease liabilities | 12,798 | 12,378 |
| Other current liabilities | 2,518 | 1,087 |
| Total current liabilities | 330,382 | 354,756 |
| Long-term debt | 238,426 | 240,826 |
| Non-current operating lease liabilities | 51,518 | 52,189 |
| Deferred revenue, non-current | 3,944 | 5,477 |
| Other non-current liabilities | 374 | 431 |
| Total liabilities | 624,644 | 653,679 |
| Stockholders’ deficit | ||
| Class A common stock—par value 0.0001; 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024 and 43,132,115 and 42,938,701 shares issued as of March 31, 2025 and December 31, 2024, respectively | 4 | 4 |
| Class B common stock—par value 0.0001; 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024 and 31,088,085 and 31,090,085 shares issued as of March 31, 2025 and December 31, 2024, respectively | 3 | 3 |
| Additional paid-in capital | 597,086 | 591,281 |
| Accumulated other comprehensive loss | (15,507) | (11,774) |
| Accumulated deficit | (613,331) | (612,154) |
| Total stockholders’ deficit | (31,745) | (32,640) |
| Total liabilities and stockholders’ deficit | $592,899 | $621,039 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.